Empresa Clarus Therapeutics Holdings, Inc.
Acciones
CRXT
US18271L1070
Farmacéuticos
Resumen de negocios
Número de empleados: 16
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Robert Dudley
FOU | Founder | 69 | 01/01/04 |
Jay Newmark
CTO | Chief Tech/Sci/R&D Officer | - | - |
Kara Stancell
IRC | Investor Relations Contact | - | - |
Sales & Marketing | - | 01/03/20 | |
Corporate Officer/Principal | - | 17/01/22 | |
James Holloway
PRN | Corporate Officer/Principal | - | - |
Lawrence Perkins
PRN | Corporate Officer/Principal | 47 | - |
Mike Cleveland
SAM | Sales & Marketing | - | 01/02/22 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Robert Dudley
FOU | Founder | 69 | 01/01/04 |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 52 020 731 | 50 674 645 ( 97,41 %) | 0 | 97,41 % |
Información de la empresa
Clarus Therapeutics Holdings, Inc.
355 South Grand Avenue Suite 1450
90071, Los Angeles
+
http://clarustherapeutics.comVaria. 1 de ene. | Capi. | |
---|---|---|
+26,08 % | 681 mil M | |
+21,85 % | 556 mil M | |
-4,77 % | 361 mil M | |
+16,97 % | 325 mil M | |
+5,69 % | 285 mil M | |
+13,68 % | 235 mil M | |
+3,65 % | 199 mil M | |
-11,12 % | 189 mil M | |
-3,40 % | 157 mil M |